An injectable gel could change the ability of contractile heart muscle cells to regenerate after myocardial infarction (MI), according to researchers at the University of Pennsylvania.

BioTelemetry, Inc., the leading mobile and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today a partnership with Apple to provide cardiac monitoring services in conjunction with the Apple Heart Study.

DUBLIN, Ohio, November 30, 2017 — Cordis, a Cardinal Health company, and Medinol today announced United States Food and Drug Administration (FDA) approval of the EluNIR™ drug-eluting stent (DES) for the treatment of patients with narrowing or blockages to their coronary arteries.

Flashing a smile—even if it’s forced—tricks the brain into believing you’re happy, triggering a multitude of health benefits, according to an NBC report.

The largest, longest trial to date testing an oral drug for obstructive sleep apnea yielded positive results, according to research out of Chicago. Dronabinol—a synthetic THC substitute—proved helpful in reducing apnea and decreasing sleepiness in 73 adult patients.

Plans to reintroduce the troubled LOTUS Edge Aortic Valve System into the European market have stalled, Boston Scientific reported Tuesday.

MADRID — Nov. 28, 2017 — MedLumics, a medical device company developing an optically guided cardiac ablation platform for the treatment of Atrial fibrillation (AF), announced today it has appointed James Greene as Chief Executive Officer and named Giovanni Leo to the board of directors.

Cardiometabolic risk may hinge less on body fat mass and more on where in a patient’s body that fat is stored, according to research presented this week at the Radiological Society of North America's annual meeting in Chicago.